Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Smith

Showing results (181-190 of 234) with videos related to

Pageof 24
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2023
Inhibition of neutral sphingomyelinase 2 impairs HIV-1 envelope formation and substantially delays or eliminates viral reboundSeung-Wan Yoo, Abdul A Waheed, Pragney Deme, et al.
Plant & Cell Physiology|December 7, 2018
An RK/ST C-Terminal Motif is Required for Targeting of OEP7.2 and a Subset of Other Arabidopsis Tail-Anchored Proteins to the Plastid Outer Envelope MembraneHoward J Teresinski, Satinder K Gidda, Thuy N D Nguyen, et al.
Annals of Clinical and Translational Neurology|February 4, 2025
Real-world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell-based assayYana Said, Angeliki Filippatou, Conlan Tran, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Accelerated Metabolomic Aging and Its Association with Social Determinants of Health in Multiple SclerosisFatemeh Siavoshi, Rezvan Noroozi, Gina Chang, et al.
Ebiomedicine|July 11, 2022
Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosisKathryn C Fitzgerald, Pavan Bhargava, Matthew D Smith, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 14, 2021
Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune EncephalomyelitisMarjan Gharagozloo, Matthew D Smith, Elias S Sotirchos, et al.
Journal of the American Chemical Society|December 15, 2016
Chemical Synthesis and Self-Assembly of a Ladderane PhospholipidJaron A M Mercer, Carolyn M Cohen, Steven R Shuken, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 20, 2023
Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosisDimitrios C Ladakis, Maria I Reyes-Mantilla, Sachin P Gadani, et al.
Science Advances|October 3, 2020
Inhibition of neutral sphingomyelinase 2 promotes remyelinationSeung-Wan Yoo, Amit Agarwal, Matthew D Smith, et al.
JCI Insight|October 10, 2024
TET2 promotes tumor antigen presentation and T cell IFN-γ, which is enhanced by vitamin CMeng Cheng, Angel Ka Yan Chu, Zhijun Li, et al.
Pageof 24

Showing results (181-190 of 234) with videos related to

Sort By:
Pageof 24
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2023
Inhibition of neutral sphingomyelinase 2 impairs HIV-1 envelope formation and substantially delays or eliminates viral reboundSeung-Wan Yoo, Abdul A Waheed, Pragney Deme, et al.
Plant & Cell Physiology|December 7, 2018
An RK/ST C-Terminal Motif is Required for Targeting of OEP7.2 and a Subset of Other Arabidopsis Tail-Anchored Proteins to the Plastid Outer Envelope MembraneHoward J Teresinski, Satinder K Gidda, Thuy N D Nguyen, et al.
Annals of Clinical and Translational Neurology|February 4, 2025
Real-world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell-based assayYana Said, Angeliki Filippatou, Conlan Tran, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Accelerated Metabolomic Aging and Its Association with Social Determinants of Health in Multiple SclerosisFatemeh Siavoshi, Rezvan Noroozi, Gina Chang, et al.
Ebiomedicine|July 11, 2022
Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosisKathryn C Fitzgerald, Pavan Bhargava, Matthew D Smith, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 14, 2021
Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune EncephalomyelitisMarjan Gharagozloo, Matthew D Smith, Elias S Sotirchos, et al.
Journal of the American Chemical Society|December 15, 2016
Chemical Synthesis and Self-Assembly of a Ladderane PhospholipidJaron A M Mercer, Carolyn M Cohen, Steven R Shuken, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 20, 2023
Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosisDimitrios C Ladakis, Maria I Reyes-Mantilla, Sachin P Gadani, et al.
Science Advances|October 3, 2020
Inhibition of neutral sphingomyelinase 2 promotes remyelinationSeung-Wan Yoo, Amit Agarwal, Matthew D Smith, et al.
JCI Insight|October 10, 2024
TET2 promotes tumor antigen presentation and T cell IFN-γ, which is enhanced by vitamin CMeng Cheng, Angel Ka Yan Chu, Zhijun Li, et al.
Pageof 24